Letter to the Editor: Kudos to Buddy Carter from Medicare patients
On behalf of Medicare patients in Georgia who rely on long term care (LTC) pharmacies for their prescription medication, I’d like to thank Congressman Buddy Carter, R-Ga., for advocating for increased transparency and fairness in prescription drug pricing.
LTC pharmacies that oversee the prescriptions for patients in skilled nursing, assisted living facilities and other long term care settings, are beholden to Pharmacy Benefit Managers (PBMs) – the middle men who oversee the pricing structure and reimbursement rate for most generic drugs dispensed by LTC pharmacies to Medicare beneficiaries under the Part D benefit.
Data demonstrates that the pricing methodologies used by these PBMs leads to arbitrary and inadequate reimbursement that puts independent LTC pharmacies and their patients at extreme risk — all while increasing profits for PBMs and the pharmacies they operate.
A pharmacist himself, Congressman Carter recently raised important questions about the pricing practices of PBMs at a Congressional hearing on U.S. Prescription drug pricing practices, during which he expressed concern about the current drug marketplace because it creates perverse incentives for PBMs to shut out independent pharmacies at the expense of the American public.
He further called for greater transparency in PBM practices.
Unfortunately, it comes down to the fact that these pricing practices by PBMs undermine the stability of independent LTC pharmacies, increasing the costs to taxpayers and ultimately jeopardizing quality patient care.
Please join me in thanking Congressman Carter for looking out for Georgia’s vulnerable Medicare beneficiaries and helping to ensure they have access to fairly priced medications.
ROBERT WARNOCK
Click here to see the original article on the Savannah Morning News website.
Recent Posts
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.